Calculate your potential cost savings
with Pradaxa (dabigatran etexilate)®
versus other NOACs
Cost
How much could you save by prescribing Pradaxa® (dabigatran etexilate) for your patients with non-valvular atrial fibrillation versus other NOACs? Use the simple cost calculator below to find out.
Calculator
If you switch your eligible patients to Pradaxa®, your potential yearly savings are
£0.00
Prices based on NHS list price.1
Annual savings per patient are calculated by multiplying the difference in the daily price of each drug relative to Pradaxa® by 365. The total savings are calculated by multiplying the savings per patient on apixaban, rivaroxaban and edoxaban by the number of patients receiving them, respectively. This calculator assumes that all of your NOAC patients are suitable for Pradaxa®. Please refer to the Pradaxa® Summary of Product Characteristics to ensure your patient is appropriate for Pradaxa® prior to prescribing.2,3
NOAC — non-vitamin K antagonist oral anticoagulant
- MIMS.co.uk (accessed July 2020).
- Pradaxa® 150mg hard capsules Summary of Product Characteristics.
- Pradaxa® 110mg hard capsules Summary of Product Characteristics.